Voriconazole safety: short review of clinical data
Veselov, A.V.; Belousov, D.I.
Antibiotiki i Khimioterapiia 51(3-4): 19-25
2006
ISSN/ISBN: 0235-2990 PMID: 17165257 Document Number: 603927
Document emailed within 1 workday
Related Documents
Newberne, J.W. 1973: Assessment of safety data from patients on short and long-term perhexiline therapy Postgraduate Medical Journal 49(Suppl 3): 125-132Schaller, M.; Hackl, W.O.; Ammenwerth, E. 2018: Improving Patient Safety by Reusing Clinical Routine Data - An Expert Survey on Patient Safety Indicators Studies in Health Technology and Informatics 248: 300-306
Gomulka, J.; Wilson, B.D.; Joyce, J.C. 2014: Toxic epidermal necrolysis due to voriconazole: case report and review Dermatology Online Journal 20(9)
Behnam, S.M.; Behnam, S.E.; Koo, J.Y. 2005: Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use Journal of drugs in dermatology: JDD 4(2): 189-194
John, M. 2011: Basal insulin analogues--a review of recent data on efficacy and safety Journal of the Association of Physicians of India 59 Suppl: 25-28
Pawlik, Bław.; Szul, A.; Macura, A.B. 2006: Susceptibility of fungi isolated from clinical materials to voriconazole Medycyna Doswiadczalna i Mikrobiologia 58(2): 155-161
Rodríguez Paredes, A.; González, J.L. 2000: Data on the safety of antihistaminics obtained from published clinical trials Allergologia et Immunopathologia 28(5): 272-277
Saito, A.; Sakai, J.; Kurihara, M.; Kami, M.; Kanda, Y.; Mori, S-ichiro.; Takaue, Y.; Ohashi, Y. 2003: Clinical safety data management in company non-sponsored trials Nihon Rinsho. Japanese Journal of Clinical Medicine 61(9): 1658-1665
Armstrong, P.W.; Furberg, C.D. 1995: Clinical trial Data and Safety Monitoring Boards. The search for a constitution Circulation 91(3): 901-904
Choi, J.; Choi, J.E. 2016: Enhancing Patient Safety Using Clinical Nursing Data: a Pilot Study Studies in Health Technology and Informatics 225: 103-107
Kumari, A.; Catanzaro, R.; Marotta, F. 2011: Clinical importance of lactic acid bacteria: a short review Acta Bio-Medica: Atenei Parmensis 82(3): 177-180
Pirotta, M.; Chondros, P. 2004: Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network Australian Family Physician 33(11): 950
Ferry, L.; Johnston, J.A. 2003: Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience International Journal of Clinical Practice 57(3): 224-230
Bhatt, A.D.; Dalal, D.G.; Shah, S.J.; Joshi, B.A.; Gajjar, M.N.; Vaidya, R.A.; Vaidya, A.B.; Antarkar, D.S. 1995: Conceptual and methodologic challenges of assessing the short-term efficacy of Guggulu in obesity: data emergent from a naturalistic clinical trial Journal of Postgraduate Medicine 41(1): 5-7
Reid, R.L.; Fortier, M.P.; Smith, L.; Mirkin, S.; Grubb, G.S.; Constantine, G.D. 2010: Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada Contraception 82(6): 497-502
Kircik, L.H. 2010: Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications Journal of Drugs in Dermatology: Jdd 9(11): 1407-1411
Zinner, R.G.; Fossella, F.V.; Herbst, R.S. 2004: Pemetrexed in advanced NSCLC: a review of the clinical data Oncology 18(8 Suppl 5: 54-62
Lee, S.Eun.; Quinn, B.L. 2020: Safety Culture and Patient Safety Outcomes in East Asia: A Literature Review Western Journal of Nursing Research 42(3): 220-230
Den Boer, J.A.; Westenberg, H.G.; Verhoeven, W.M. 1989: Negative symptoms and schizophrenia. a concise review of clinical and pharmacotherapeutic data L'Encephale 15(2): 273-282
Schultz-Hector, S.; Kallfass, E.; Sund, M. 1995: Radiation sequelae in the large arteries. a review of clinical and experimental data Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(8): 427-436